Clinical Trial Update: MRI Study With Ferumoxytol in Assessing Early Response in Patients With Glioblastoma Multiforme Receiving Temozolomide and Radiation Therapy [NA]

View source ↗

Summary

A completed trial evaluated MRI using ferumoxytol to assess early response in patients with glioblastoma receiving temozolomide and radiation therapy. Results h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Feraheme (ferumoxytol)

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Adult Brain Glioblastoma | NA | Status: COMPLETED | Results posted: 2016-05-16